P-972 Pilot study of SGN-15 immunoconjugate with docetaxel as firstline therapy for NSCLC with FDG-PET assessment of response
Ross, H., Rarick, M., Rudin, C., Wahl, R., Vansant, J., Leal, J., Grove, L., Miller, D., McDonald, M.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/S0169-5002(05)81465-5
Date:
July, 2005
File:
PDF, 286 KB
english, 2005